Cases of high consequence infectious diseases identified in the UK, 1962–2023
Atkinson B. et al, (2025), Journal of Medical Microbiology, 74
Case series of the first five human infections with monkeypox virus clade Ib and report on the public health response, United Kingdom, October to November 2024
Alvi MI. et al, (2025), Eurosurveillance, 30
Evaluation of the diagnostic accuracy of Xpert® Mpox and STANDARD™ M10 MPX/OPX for the detection of monkeypox virus
Romero-Ramirez A. et al, (2025), Journal of Infection, 90
Inferring transmission risk of respiratory viral infection from the viral load kinetics of SARS-CoV-2, England, 2020 to 2021 and influenza A virus, Hong Kong, 2008 to 2012.
Jonnerby J. et al, (2025), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 30
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
Pesonel E. et al, (2025), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Ebola disease: bridging scientific discoveries and clinical application.
Rojek A. et al, (2024), The Lancet. Infectious diseases
Global High-Consequence Infectious Disease Readiness and Response: An Inventory of High-Level Isolation Units
Stern KL. et al, (2024), Health Security
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Chan XHS. et al, (2024), The Lancet Microbe, 101002 - 101002
Clinical Management of Hospitalized Patients With High-Consequence Infectious Diseases in England.
Alonso A. et al, (2024), Health security, 22, S50 - S65
Global Clinical Networking to Optimize the Clinical Management of High-Consequence Infectious Diseases.
Herstein JJ. et al, (2024), Health security, 22, S1 - S3
The worsening mpox outbreak in Africa: a call to action.
Kuppalli K. et al, (2024), The Lancet. Infectious diseases
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591
Rapid emergence of transmissible SARS-CoV-2 variants in mild community cases.
Crone MA. et al, (2024), Microbiology spectrum
Mpox: The alarm went off. Have we gone back to sleep?
Olliaro P. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011871 - e0011871
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.
Bourner J. et al, (2024), PloS one, 19
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.
Devine K. et al, (2024), Clinical endocrinology
Variability in clinical assessment of clade IIb mpox lesions
Jones B. et al, (2023), International Journal of Infectious Diseases, 137, 60 - 62
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity.
Swets MC. et al, (2023), Nature communications, 14
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.
Reyes LF. et al, (2023), Journal of critical care, 77
Mpox virus DNA contamination can still be detected by qPCR analysis after autoclaving.
Spencer A. et al, (2023), The Journal of hospital infection
COVID-19 risk mitigation in reopening mass cultural events: population-based observational study for the UK Events Research Programme in Liverpool City Region.
Burnside G. et al, (2023), Journal of the Royal Society of Medicine
Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study.
Derqui N. et al, (2023), The Lancet. Microbe, 4, e397 - e408
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
An opportunity seized: rapid clinical research provides insights into monkeypox virus dynamics and durations of infectiousness
Dunning J. and Ochu C., (2023), The Lancet Infectious Diseases, 23, 383 - 385
Randomised controlled trials for mpox in endemic countries.
Rojek A. et al, (2023), The Lancet. Infectious diseases, 23
Longitudinal mpox virus surface sampling in an outpatient setting.
Atkinson B. et al, (2023), J Hosp Infect
High consequence infectious diseases in Europe - the need for an expert clinical support service
Brantsæter A. et al, (2023), Population Medicine, 5, 116 - 116
MOSAIC: A cohort study of human mpox virus disease.
Pesonel E. et al, (2023), Wellcome open research, 8
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.
Fink DL. et al, (2022), The Lancet. Infectious diseases
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
Kundu R. et al, (2022), Nature Communications, 13
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases
Hassoun-Kheir N. et al, (2022), Clinical Microbiology and Infection, 28, 1528 - 1532
Tecovirimat for Monkeypox in Central African Republic under Expanded Access.
Mbrenga F. et al, (2022), The New England journal of medicine, 387, 2294 - 2295
Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients
Baruch J. et al, (2022), Influenza and Other Respiratory Viruses, 16, 1040 - 1050
Monkeypox as an emerging infectious disease: the ophthalmic implications
Milligan AL. et al, (2022), British Journal of Ophthalmology
Air and surface sampling for monkeypox virus in a UK hospital: an observational study
Gould S. et al, (2022), The Lancet Microbe
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses.
Needham EJ. et al, (2022), Brain : a journal of neurology
Evolutionary implications of human transmission of monkeypox: the importance of sequencing multiple lesions.
Ulaeto DO. et al, (2022), The Lancet. Microbe, 3, e639 - e640
Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number
Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737
Monkeypox: how will we know if the treatments work?
Rojek A. et al, (2022), The Lancet. Infectious diseases, 22, 1269 - 1270
Clinical features and management of human monkeypox: a retrospective observational study in the UK
Adler H. et al, (2022), The Lancet Infectious Diseases, 22, 1153 - 1162
Monkeypox virus contamination in an office-based workplace environment.
Atkinson B. et al, (2022), The Journal of hospital infection
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study
Hakki S. et al, (2022), The Lancet Respiratory Medicine
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Abbas A. et al, (2022), Scientific Data, 9
Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts.
Houston H. et al, (2022), The European respiratory journal, 60
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Knight SR. et al, (2022), Thorax, 77, 606 - 615